Imatinib adyuvante en GIST
- Dematteo RP, Ballman KV, Antonescu CR, et al, for the American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant GIST Study Team. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet. 2009 Mar 28;373(9669):1097-104
jueves, 9 de abril de 2009
Suscribirse a:
Entradas (Atom)